Welcome to our dedicated page for Envista Holdings SEC filings (Ticker: NVST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Envista Holdings Corporation filings document formal disclosures for a Delaware dental products issuer with common stock listed under NVST. Recent Form 8-K reports furnish quarterly financial results under Item 2.02, Regulation FD materials for earnings presentations, and corporate disclosures such as sustainability-report announcements.
The company's proxy materials cover board governance, executive compensation, equity awards and shareholder voting matters. Other material-event filings document director changes and related governance updates, while the filing record also identifies the company's Exchange Act reporting framework, capital-stock context and furnished status of investor materials.
Envista Holdings Corp executive Mischa Reis reported mixed equity compensation activity. On February 25, Reis received 10,770 Performance Share Units that may vest over a three-year performance period, with actual payout ranging from 0% to 200% of this target amount based on performance certification.
On the same date, Reis was granted 14,020 stock options that vest in three equal annual installments, and 5,915 restricted stock units that also vest ratably over three years, each converting into one share of common stock. In connection with the vesting of previously granted RSUs, 2,976 shares of common stock were withheld at $29.59 per share to cover tax obligations, reducing open-market impact. After these transactions, Reis directly owned 35,321 shares of common stock.
Envista Holdings Corp General Counsel Mark E. Nance reported equity compensation changes and related tax withholding. On February 25, 2026, he received 23,070 Performance Share Units, which can pay out between 0%-200% of this target amount based on three-year performance measures.
He was also granted 30,040 stock options that vest in equal annual installments over three years, and 12,675 shares of common stock tied to Restricted Stock Units that vest ratably on each anniversary of the grant date over three years. To cover tax obligations from RSU vesting, 3,368 shares of common stock were withheld at $29.59 per share, reducing the need for a separate cash payment.
Envista Holdings Corp Chief Accounting Officer Faez C. Kaabi reported two equity-related transactions involving company common stock. On the same date, 4,964 shares were disposed of at $29.59 per share to satisfy tax withholding obligations tied to the vesting of previously granted stock-settled RSUs.
Kaabi also acquired 13,520 RSUs as a grant that will vest in three equal annual installments, each RSU converting into one share of common stock upon vesting, subject to continued service. Following these transactions, Kaabi directly owned 58,552 shares of Envista common stock.
Envista Holdings Corp CEO Paul A. Keel reported a mix of equity awards and a small tax‑related share disposition. He received 132,885 Performance Share Units, which can pay out between 0% and 200% of this target amount based on three‑year performance goals. He was also granted 115,320 stock options and 48,670 Restricted Stock Units, each scheduled to vest in equal installments over three years, contingent on continued service. To cover tax withholding on vested RSUs, 11,840 common shares were withheld at $29.59 per share, leaving him with 384,385 common shares directly owned.
Envista Holdings Corp reported that Robert Befidi, its President, Diagnostics, received several equity awards. He was granted 13,845 Performance Share Units, which can pay out between 0% and 200% of this target amount depending on performance over a three-year period.
He also received 18,020 employee stock options that vest in three equal annual installments, and 7,605 restricted stock units that likewise vest ratably over three years, all subject to continued service. Separately, 2,177 common shares were withheld at $29.59 per share to cover tax obligations on vesting RSUs, leaving him with 50,932 common shares directly owned.
Envista Holdings Corporation reports 2025 sales of $2.7 billion, up from $2.5 billion in 2024, driven by its global dental product portfolio. The Specialty Products & Technologies segment contributed 64% of sales, with Equipment & Consumables providing 36%.
North America generated 51% of revenue, Western Europe 23%, emerging markets 22%, and other developed markets 4%. Emerging market sales reached $586 million. The company highlights growth in implants, orthodontic clear aligners and digital imaging, alongside a strong focus on EBS-driven cost control, R&D investment and human capital development.
Envista Holdings senior vice president of Strategy & Business Development Mischa Reis exercised stock options and sold the resulting shares on February 10, 2026. He exercised options for 4,041 shares at $19.04 and 5,634 shares at $15.97, then sold the same share amounts at $30 per share under a pre‑adopted Rule 10b5-1 trading plan, ending with 32,382 common shares held directly.
Envista Holdings (NVST) has a shareholder who filed a Form 144 notice to sell 9,675 common shares, with an aggregate market value of $290,250.00. The planned sales are to be executed through Fidelity Brokerage Services LLC on the NYSE around February 10, 2026.
The securities were acquired by exercising stock options originally granted on May 15, 2017 and February 24, 2018. The holder acquired 5,634 shares from the 2017 grant and 4,041 shares from the 2018 grant on February 10, 2026, paying the exercise price in cash.
Envista Holdings Corporation furnished an update on its recent performance by issuing a press release with financial results for the quarter ended December 31, 2025. The company also prepared an investor slide presentation to accompany its earnings conference call, available through the investors section of its website.
Both the earnings release, filed as Exhibit 99.1, and the presentation referenced under Regulation FD are being furnished rather than filed, which means they are not automatically incorporated into other securities law filings unless specifically referenced.
Envista Holdings Corp. President, Diagnostics Robert Befidi reported an automatic award of 998 notional shares linked to Envista stock on February 1, 2026. These units were credited to his Envista deferred contribution program at a reference price of $23.47 per share and convert one-for-one into common stock under the plan terms.
After this company contribution, Befidi holds 2,149 notional shares in the Envista stock fund within the Excess Contribution Program. The award consists of unfunded, notional units that reflect matching or non‑elective contributions, which vest over time based on service and anniversary dates.